We can’t show the full text here under this license. Use the link below to read it at the source.
Effect of beinaglutide treatment on weight loss in Chinese patients with type 2 diabetes mellitus and overweight/obesity
Beinaglutide treatment and weight loss in Chinese adults with type 2 diabetes and overweight or obesity
AI simplified
Abstract
After three months of beinaglutide treatment, participants experienced significant weight loss and improvements in several metabolic markers.
- Participants had reductions in body weight, BMI, fasting plasma glucose, and glycosylated hemoglobin after treatment.
- Visceral and subcutaneous fat areas also decreased significantly following the three-month intervention.
- Levels of inflammatory markers such as serpin E1, leptin, C-reactive protein, and tumor necrosis factor-α decreased significantly.
- A positive correlation was observed between the percentage of weight loss and plasma concentrations of C-reactive protein.
AI simplified